As we age, our bodies undergo a series of changes. While some are visible, others occur at the cellular level. New research has uncovered a surprising link between a common antibody and the aging ...
Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that attack ...
BHV-1300 reduced total IgG by up to 84% in a four-week Phase 1 study. The treatment was well-tolerated, with no serious adverse events reported. Get access to the leaderboards pointing to tomorrow’s ...
Many patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma do not undergo immunoglobulin G testing despite its potential to reduce likelihood of severe infections. Blood cancers increase ...
Please provide your email address to receive an email when new articles are posted on . Systemic corticosteroids can lead to CD4 lymphopenia and lower IgG levels. Rituximab therapy can lead to ...
On Monday, Biohaven Ltd. (NYSE:BHVN) revealed clinical and regulatory milestones across its proprietary Molecular Degrader of Extracellular Proteins (MoDE) platform and its glutamate modulation and ...
LUND, Sweden, Oct. 7, 2024 /PRNewswire/ -- Hansa Biopharma AB, ("Hansa" or the "Company") (NASDAQ STOCKHOLM: HNSA), today announced positive results from a 12-month follow up analysis from the NICE-01 ...
Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback